Full Name
Michelle Nguyen
Job Title
Associate Professor of Surgery, Transplant Surgeon
Company/Institution/ Organization
Mayo clinic
Speaker Bio
Michelle C. Nguyen, M.D., M.P.H. is a consultant in the Division of Transplant Surgery at Mayo Clinic in Arizona and an associate professor of surgery at the Mayo Clinic College of Medicine and Science. She joined Mayo Clinic in 2021. Dr. Nguyen earned her B.S. in microbiology and M.D. with Research Distinction from the University of Iowa, followed by an M.P.H. in clinical translational science and general surgery residency at The Ohio State University. She completed multi-organ transplant fellowship training at Johns Hopkins and is a Fellow of the American College of Surgeons.
A board-certified abdominal transplant surgeon, Dr. Nguyen specializes in adult liver, kidney, pancreas, and multi-organ transplantation. She led the development of Mayo Clinic Arizona’s robotic transplant surgery program, including robotic living donor nephrectomy and robotic kidney and kidney/pancreas transplantation.
She previously led a Kemper and Ethel Marley Foundation–funded study of biliary and perfusate biomarkers in normothermic machine perfusion (NMP) liver grafts and co-directs RELIVERATE, a regenerative bioengineering initiative that uses AI-enabled perfusion and targeted cellular and RNA-based therapies to restore discarded livers for transplantation. She is site PI for a Terasaki Institute biosensor collaboration (Real-Time Monitoring of Organ Health from Procurement to Transplant Surgery) and PI of the 2025 ASTS TransMedics Faculty Perfusion Grant on real-time biomarker assessment during NMP. Through the Mayo Clinic Advanced Innovation Research (MC-AIR) program, she leads the 2025 SMART-Organ project (Sensing Metabolic, Anti-inflammatory, and Rejection Trends for Organ Health) and the 2026 Anti-FAP CAR-T–enabled ex vivo liver defibrosis project. She also serves as project lead for the Liver Perfusion and Transplant Outcomes initiative within the Mayo Clinic Center for Policy and Outcomes Research.
Her work has been presented at major national and international meetings and published in leading journals. Nationally, she serves as chair of the ASTS Fellowship Training Committee, helping shape the next generation of transplant surgeons.
A board-certified abdominal transplant surgeon, Dr. Nguyen specializes in adult liver, kidney, pancreas, and multi-organ transplantation. She led the development of Mayo Clinic Arizona’s robotic transplant surgery program, including robotic living donor nephrectomy and robotic kidney and kidney/pancreas transplantation.
She previously led a Kemper and Ethel Marley Foundation–funded study of biliary and perfusate biomarkers in normothermic machine perfusion (NMP) liver grafts and co-directs RELIVERATE, a regenerative bioengineering initiative that uses AI-enabled perfusion and targeted cellular and RNA-based therapies to restore discarded livers for transplantation. She is site PI for a Terasaki Institute biosensor collaboration (Real-Time Monitoring of Organ Health from Procurement to Transplant Surgery) and PI of the 2025 ASTS TransMedics Faculty Perfusion Grant on real-time biomarker assessment during NMP. Through the Mayo Clinic Advanced Innovation Research (MC-AIR) program, she leads the 2025 SMART-Organ project (Sensing Metabolic, Anti-inflammatory, and Rejection Trends for Organ Health) and the 2026 Anti-FAP CAR-T–enabled ex vivo liver defibrosis project. She also serves as project lead for the Liver Perfusion and Transplant Outcomes initiative within the Mayo Clinic Center for Policy and Outcomes Research.
Her work has been presented at major national and international meetings and published in leading journals. Nationally, she serves as chair of the ASTS Fellowship Training Committee, helping shape the next generation of transplant surgeons.
Speaking At
